Torrent Pharma`s Generic Doxycycline Hyclate Receives Approval in the U.S.
Lupin's Generic Doxycycline Hyclate Receives Approval in the U.S.
Par Sterile's Generic Doxycycline Hyclate Receives Approval in the U.S.
Amneal's Generic Doxycycline Hyclate Receives Approval in the U.S.
Praxgen's Generic Doxycycline Hyclate Receives Approval in the U.S.
Alembic Pharmaceuticals today received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate delayed-release tablets USP, 75 mg, 100 mg, 150 mg, and 200 mg. The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Doryx tablets, 75 mg, 100 mg, 150 mg and 200 mg, of Mayne Pharma International, Alembic Pharma notified via a statement.
Alembic's Generic Doxycycline Hyclate Receives Approval in the U.S.
Nesher Pharma's Generic Doxycycline Hyclate Receives Approval in the US
Oryza `s Generic Doxycycline Hyclate Receives Approval In US